A chemistry engineer by training, Nicolas began his career in 1989 at Arkopharma laboratories, where he held various positions until the commercial management of the subsidiary LHS. In this capacity, he is in charge of the management of all custom manufacturing for third parties (he designs all ranges of EA Pharma).
In 1999, he joined EA Pharma as General Manager and doubled the company's turnover within 3 years.
In 2003, he founded Laboratoires Ineldea with the aim of developing specific product lines for the emerging market segments: he launched PEDIAKID and OLIOSEPTIL.
“The Natural Health market is estimated at 11 billion €uros and currently represents more than 200 companies in Europe. Our decision to partner with Mérieux Développement, as a new reference shareholder of Ineldea Laboratories, is clearly in line with our desire to boost our presencein this fast growing market, through organic growth and acquisition. We are delighted that Mérieux Développement, a renowned and investor with strong expertise in our sector, supports us to get to the next stage of our company journey.”